报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 68.42% | -1.19% | -3.02% | 36/129 | 53.43% | 佰仁医疗 | 88.56% | 行业排名> |
2024-06-30 | 70.56% | -1.7% | -2.17% | 27/129 | 53.65% | 佰仁医疗 | 89.27% | 行业排名> |
2024-03-31 | 72.12% | 1.54% | 5.3% | 24/129 | 53.62% | 佰仁医疗 | 89.28% | 行业排名> |
2023-12-31 | 68.49% | -3.63% | -1.09% | 33/129 | 53.75% | 正海生物 | 89.9% | 行业排名> |
2023-09-30 | 69.25% | -3.8% | -3.52% | 29/129 | 54.06% | 正海生物 | 90.39% | 行业排名> |
2023-06-30 | 71.78% | -0.61% | 1.05% | 19/129 | 53.61% | 正海生物 | 90.3% | 行业排名> |
2023-03-31 | 71.03% | 0.21% | -0.06% | 22/129 | 53.66% | 正海生物 | 89.78% | 行业排名> |
2022-12-31 | 71.08% | -8.78% | -1.26% | 24/129 | 54.04% | 三友医疗 | 90.18% | 行业排名> |
2022-09-30 | 71.99% | -7.81% | -0.32% | 23/129 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
2022-06-30 | 72.22% | -8.72% | 1.89% | 23/129 | 54.78% | 三友医疗 | 90.29% | 行业排名> |
2022-03-31 | 70.88% | -8.62% | -9.03% | 27/129 | 56.28% | 三友医疗 | 90.73% | 行业排名> |
2021-12-31 | 77.92% | -2.32% | -0.22% | 13/129 | 57.38% | 三友医疗 | 90.5% | 行业排名> |
2021-09-30 | 78.09% | -3.72% | -1.31% | 14/129 | 59.17% | 三友医疗 | 90.29% | 行业排名> |
2021-06-30 | 79.12% | -1.25% | 2% | 14/129 | 58.42% | 正海生物 | 90.78% | 行业排名> |
2021-03-31 | 77.57% | -4.75% | -2.75% | 15/129 | 60.75% | 正海生物 | 91.59% | 行业排名> |
2020-12-31 | 79.77% | -4.68% | -1.65% | 15/129 | 59.67% | 正海生物 | 92.23% | 行业排名> |
2020-09-30 | 81.1% | 15.56% | 1.23% | 14/129 | 61.59% | 正海生物 | 92.69% | 行业排名> |
2020-06-30 | 80.12% | -4.27% | -1.62% | 18/129 | 59.94% | 正海生物 | 92.61% | 行业排名> |
2020-03-31 | 81.44% | 2% | -2.69% | 9/129 | 58.33% | 正海生物 | 94.38% | 行业排名> |
2019-12-31 | 83.69% | 0.87% | -0.01% | 11/129 | 56.37% | 正海生物 | 93.12% | 行业排名> |
2019-06-30 | 83.7% | 2% | 0.88% | 8/129 | 57.37% | 正海生物 | 93.78% | 行业排名> |
2018-12-31 | 82.97% | -0.53% | -0.53% | 9/129 | 55.53% | 正海生物 | 93.09% | 行业排名> |
2017-12-31 | 83.41% | 1.38% | 1.38% | 7/129 | 55.34% | 正海生物 | 93.85% | 行业排名> |
2016-12-31 | 82.27% | 21.8% | 17.23% | 9/129 | 56.43% | 正海生物 | 93.08% | 行业排名> |